Evaluating the Impact of Sleep on Psoriasis and Associated Comorbidities

Tina Buthani M.D.

Sleep impairment is a risk factor for cardiovascular disease and metabolic disorders. Research shows that psoriasis patients are more likely to report sleep disturbance compared to people without psoriasis. This proposal aims to objectively measure sleep disturbance in psoriasis patients, describe differences in sleep patterns between psoriasis patients and controls, and determine whether sleep is a modifier for the development of psoriasis-associated cardiometabolic comorbidities.

— Tina Bhutani, M.D., MAS

Related Articles

Crystal Aguh M.D.

Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia

Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…

Read More

Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus

Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…

Read More

Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy

Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…

Read More